MADCAM1 and inflammatory bowel disease: Since expression of MAdCAM-1 was present in the livers of PSC patients, we hypothesized that there was also an increase in MAdCAM-1 expression in the intestine of patients with PSC-IBD, leading to a more general increased homing potential of α4β7+ T-cells in patients with PSC-IBD.